A 2025 meta-analysis in Scientific Reports found that GLP-1 receptor agonists reduced body weight, BMI, and insulin resistance in women with PCOS, although nausea, vomiting, and dizziness were more common
CVS Restores Coverage of Lillys Zepbound, Adds Oral Obesity Drug Foundayo Nicholas Jacobus Key Takeaways Zepbounds return as a preferred option reverses a prior formulary exclusion that maintained Wegovy coverage, underscoring how net pricing and rebate contracting drive PBM obesity access decisions
Hyclone) and antibiotic/antimycotic solution (Gibco BRL, Gaithersburg, MD, USA) containing penicillin and streptomycin at 37 C in a 5% CO 2 incubator
Gold standard Fourier shell correlation (FSC) curves, showing the overall nominal resolution at 4.1 (blue) and 3.9 (red) on the stable region including hGLP-1, transmembrane domain and the 5-helix the G s Ras-like domain